{{Rsnum
|rsid=2274894
|Gene=NOS2
|Chromosome=17
|position=27772145
|Orientation=plus
|GMAF=0.3104
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=NOS2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 33.6 | 45.1 | 21.2
| HCB | 47.1 | 44.1 | 8.8
| JPT | 55.8 | 38.1 | 6.2
| YRI | 81.6 | 17.7 | 0.7
| ASW | 73.7 | 24.6 | 1.8
| CHB | 47.1 | 44.1 | 8.8
| CHD | 42.6 | 50.0 | 7.4
| GIH | 71.3 | 23.8 | 5.0
| LWK | 71.8 | 26.4 | 1.8
| MEX | 36.2 | 48.3 | 15.5
| MKK | 78.8 | 21.2 | 0.0
| TSI | 39.2 | 44.1 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19575238
|Title=NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans
|OA=1
}}

{{PMID Auto
|PMID=19168583
|Title=Nitric oxide synthase gene polymorphisms and prostate cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}